Healthcare
from24/7 Wall St.
5 days agoBiotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned
Equal-weight biotech ETF FBT surged 29% in a year, benefiting from lower interest rates, improving fundamentals, and broad diversification across genomics and established companies.